Biopharmaceutical companies raised $19.5bn in venture capital through the third quarter of 2020 and now Pitchbook and the National Venture Capital Association (NVCA) have revealed that the industry brought in a total of $27.4bn last year, beating the prior record of $19.8bn in 2018 by a wide margin.
The Venture Monitor produced by Pitchbook and the NVCA with support from Silicon Valley Bank (SVB) and Velocity Global showed...






